PlainRecalls
FDA Drug Moderate Class II Ongoing

Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: Sun Pharmaceutical Industries Limited, Mohali, INDIA, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 63304-089-13.

Reported: March 6, 2024 Initiated: February 5, 2024 #D-0350-2024

Product Description

Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: Sun Pharmaceutical Industries Limited, Mohali, INDIA, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 63304-089-13.

Reason for Recall

Failed Dissolution Specifications: Out of specification for dissolution.

Details

Units Affected
54,960 bottles
Distribution
Nationwide in the U.S.
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: Sun Pharmaceutical Industries Limited, Mohali, INDIA, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 63304-089-13.. Recalled by SUN PHARMACEUTICAL INDUSTRIES INC. Units affected: 54,960 bottles.
Why was this product recalled?
Failed Dissolution Specifications: Out of specification for dissolution.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 6, 2024. Severity: Moderate. Recall number: D-0350-2024.